All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling-Reference-Cited by-同舟云学术

All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling

Published:2017-09 Issue:3 Volume:491 Page:721-726
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Leem Ah Young,Shin Mi Hwa,Douglas Ivor S.,Song Joo Han,Chung Kyung Soo,Kim Eun Young,Jung Ji Ye,Kang Young Ae,Chang Joon,Kim Young Sam,Park Moo Suk^ORCID

Funder

Yonsei University College of Medicine

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis;Tabata;Am. J. Respir. Crit. Care Med.,2006

2. The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice;Dong;Exp. Lung Res.,2012

3. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-beta1/Smad3 signaling pathway in rats;Song;Lab. Invest.,2013

4. All-trans-retinoic acid (ATRA) is of no benefit in bleomycin-induced lung injury;Segel;Pulm. Pharmacol. Ther.,2001

5. Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease;Miyagawa;Pharmacology,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catalpol ameliorates liver fibrosis inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway;Phytomedicine;2024-09

2. Retinoic acid signaling pathway in pancreatic stellate cells: Insight into the anti-fibrotic effect and mechanism;European Journal of Pharmacology;2024-03

3. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14

4. ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis;International Immunopharmacology;2023-08

5. Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis;Metabolism;2023-07